reference/9855891

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9855891

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	542
issn	1365-2362 0014-2972
issueIdentifier	8
pageRange	535-542
publicationName	European Journal of Clinical Investigation
startingPage	535
bibliographicCitation	Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest. 2004 Aug;34(8):535–42. doi: 10.1111/j.1365-2362.2004.01381.x. PMID: 15305887.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c524304353f2e00e0bd2578723a64f0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70936d17509cebe9fb8f72a7c46f6e0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b657e6f5abfdc5428766d1ab14f8aac4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7a23dd5b043960ee21297731f9182ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83ae85018275ea399619a1fe80e0b6a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e3dda6e69d23a4c94bd494ccbf29aca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_491ad9530edea652190b7ad124c64425 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fcb390cc045eba10e8ac5d33ba3a5af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_509bcfef4f2933b62d810905344e536b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1da3035323a3085a008312b52077288
date	200408
identifier	https://pubmed.ncbi.nlm.nih.gov/15305887 https://doi.org/10.1111/j.1365-2362.2004.01381.x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3611 https://portal.issn.org/resource/ISSN/1365-2362 https://portal.issn.org/resource/ISSN/0014-2972
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients
discusses	http://id.nlm.nih.gov/mesh/M0161111 http://id.nlm.nih.gov/mesh/M0009266 http://id.nlm.nih.gov/mesh/M0020795 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0010114
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013453Q000008 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D005907Q000008 http://id.nlm.nih.gov/mesh/D003924Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006442Q000032 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D007004Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003924Q000097 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D007003Q000517 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005907Q000009 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D013453Q000009 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1fa591128e20aed5298081f96090e2b3 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104818 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ac5585d98646d255299c359140537783 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3475 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3fe1944ff40134a85813108aead7ab15 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127546735 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128694473 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765044 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136148460 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136164596

Total number of triples: 65.